SummitTX Capital »

Eliem Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $141k 11k 13.04

More positions owned by SummitTX Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Analog Devices (ADI)
MKS Instruments (MKSI)
Asml Hldg Nv N Y Registry Shs (ASML)
Warner Bros Discovery Com Ser A (WBD)
Applied Materials (AMAT)
Select Sector Spdr Tr St Str Indl Etf (XLI)
Nxp Semiconductors N V (NXPI)
Amazon (AMZN)
O'reilly Automotive (ORLY)
Cbre Group Cl A (CBRE)
Electronic Arts (EA)
Micron Technology (MU)
3M Company (MMM)

View all positions for SummitTX Capital

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics